TScan Therapeutics
TCRX
#9002
Rank
โ‚ฌ84.26 M
Marketcap
1,39ย โ‚ฌ
Share price
-1.25%
Change (1 day)
-80.70%
Change (1 year)

EPS for TScan Therapeutics (TCRX)

EPS in 2023 (TTM): -2,73ย โ‚ฌ

According to TScan Therapeutics's latest financial reports the company's current EPS (TTM) is -2,53ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,41ย โ‚ฌ a decrease over its 2021 EPS that were of -1,91ย โ‚ฌ.

EPS history for TScan Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,73ย โ‚ฌ13.27%
2022-2,41ย โ‚ฌ26.25%
2021-1,91ย โ‚ฌ99.58%
2020-0,96ย โ‚ฌ